A measure of chronic quality of life predicts socioeconomic and medical outcomes in psoriasis patients

Journal of the European Academy of Dermatology and Venereology

Volumn 29, Issue 2, 2015, Pages 249-254

  Kim, G E ^a   Seidler, E ^b   Kimball, A B ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECREATIONAL DRUG;

ADULT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DEPRESSION; DERMATOLOGY LIFE QUALITY INDEX; DISEASE SEVERITY; EDUCATIONAL STATUS; EMPLOYMENT DISCRIMINATION; FEMALE; HEALTH STATUS; HUMAN; JOB PERFORMANCE; LIFESPAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PEER GROUP; PERSONAL EXPERIENCE; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRE; RETROSPECTIVE STUDY; SMOKING; SOCIAL ACCEPTANCE; SOCIAL INTERACTION; SOCIOECONOMICS; WEIGHT GAIN; MIDDLE AGED; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SOCIAL DISCRIMINATION;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SOCIAL DISCRIMINATION;

EID: 84921593802     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12503     Document Type: Article

References (19)

1. Picardi A, Abeni D, Meichi CF, Puddu P, Pasquini P,. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 2000; 143: 983-991.
2. Vardy D, Besser A, Amir M, Gesthalter B, Biton A, Buskila D,. Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life of psoriasis patients. Br J Dermatol 2002; 147: 736-742.
3. Anderson RT, Rajagopalan R,. Development and validation of a quality of life instrument for cutaneous diseases. J Am Acad Dermatol 1997; 37: 41-50.
4. Finlay AY, Khan GK,. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
5. Kimball AB, Gieler U, Linder D, Sampogna F, Warren RB, Augustin M,. Psoriasis: is the impairment to a patient's life cumulative? J Eur Acad Dermatol Venereol 2010; 24: 989-1004.
6. Warren RB, Kleyn CE, Gulliver WP,. Cumulative life course impairment in psoriasis: patient perception of disease-related impairment throughout the life course. Br J Dermatol 2011; 164: 1-14.
7. Kim GE, Seidler E, Kimball AB,. The relative impact of psoriasis and obesity on socioeconomic and medical outcomes in psoriasis patients. J Eur Acad Dermatol Venereol 2014; 28: 216-221.
8. Fredriksson T, Pettersson U,. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 1978; 157: 238-244.
9. Fleischer AB Jr, Feldman SR, Derkle CL,. The SAPASI is valid and responsive to disease severity changes in a multi-center clinical trial. J Dermatol 1999; 26: 210-215.
10. Kimball AB, Jacobson C, Weiss S, Vreeland MG, Wu Y,. The psychosocial burden of psoriasis. Am J Clin Dermatol 2005; 6: 383-392.
11. Weiss SC, Kimball AB, Liewehr DJ, Blauvelt A, Turner ML, Emanuel EJ,. Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol 2002; 47: 512-518.
12. Touw CR, Hakkaart-Van Roijen L, Verboom P, Paul C, Rutten FF, Finlay AY,. Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporine. Br J Dermatol 2001; 144: 967-972.
13. Basra MK, Hussain S,. Application of the dermatology life quality index in clinical trials of biologics for psoriasis. Clin J Integr Med 2012; 18: 179-185.
14. Krenzer S, Radtke M, Schmitt-Rau K, Augustin M,. Characterization of patient-reported outcomes in moderate to severe psoriasis. Dermatology 2011; 223: 80-86.
15. Hrehorõw E, Salomon J, Matusiak L, Reich A, Szepietowski JC,. Patients with psoriasis feel stigmatized. Acta Derm Venerol 2012; 92: 67-72.
16. Hayes J, Koo J,. Psoriasis: depression, anxiety, smoking, and drinking habits. Dermatol Therapy 2010; 23: 174-180.
17. Gupta MA, Gupta AK,. Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis and chronic idiopathic urticaria. Ann N Y Acad Sci 1999; 885: 394-395.
18. Hawro T, Miniszewska J, Chodkiewicz J, Sysa-Hedrzejowska A, Zalewska A,. Anxiety, depression and social support in patient with psoriasis. Przegl Lek 2007; 64: 568-571.
19. Gupta MA, Gupta AK, Watteel GN,. Perceived deprivation of social touch in psoriasis is associated with greater psychological morbidity: an index of the stigma experience in dermatologic disorders. Cutis 1998; 61: 339-334.